{"id":"https://openalex.org/W1524934458","doi":"https://doi.org/10.1111/j.1471-4159.2005.03149.x","title":"Chronic fluoxetine administration inhibits extracellular signal\u2010regulated kinase 1/2 phosphorylation in rat brain","display_name":"Chronic fluoxetine administration inhibits extracellular signal\u2010regulated kinase 1/2 phosphorylation in rat brain","alternate_titles":[],"publication_year":2005,"publication_date":"2005-05-16","ids":{"openalex":"https://openalex.org/W1524934458","doi":"https://doi.org/10.1111/j.1471-4159.2005.03149.x","mag":"1524934458","pmid":"https://pubmed.ncbi.nlm.nih.gov/15935071"},"language":"en","primary_location":{"id":"doi:10.1111/j.1471-4159.2005.03149.x","doi":"https://doi.org/10.1111/j.1471-4159.2005.03149.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2005.03149.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1524934458"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014663258","display_name":"Fabio Fumagalli","orcid":"https://orcid.org/0000-0002-8814-7706","observed_orcids":["https://orcid.org/0000-0002-8814-7706"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Fumagalli","raw_affiliation_strings":["Center of Neuropharmacology, Department of Pharmacological Sciences, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Neuropharmacology, Department of Pharmacological Sciences, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039648237","display_name":"Raffaella Molteni","orcid":"https://orcid.org/0000-0002-5481-7572","observed_orcids":["https://orcid.org/0000-0002-5481-7572","https://orcid.org/0000-0001-6605-2346"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Molteni","raw_affiliation_strings":["Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061882941","display_name":"Francesca Calabrese","orcid":"https://orcid.org/0000-0001-7946-2424","observed_orcids":["https://orcid.org/0000-0001-7946-2424"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Calabrese","raw_affiliation_strings":["Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067024262","display_name":"Angelisa Frasca","orcid":"https://orcid.org/0000-0002-0963-9789","observed_orcids":["https://orcid.org/0000-0002-0963-9789"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Frasca","raw_affiliation_strings":["Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040561724","display_name":"Giorgio Racagni","orcid":"https://orcid.org/0000-0002-9396-4647","observed_orcids":["https://orcid.org/0000-0002-9396-4647"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Racagni","raw_affiliation_strings":["Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088466553","display_name":"Marco Andrea Riva","orcid":"https://orcid.org/0000-0002-1699-5060","observed_orcids":["https://orcid.org/0000-0002-1699-5060"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. A. Riva","raw_affiliation_strings":["Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Neuropharmacology, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases (CEND), University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I189158943"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":6.4385,"has_fulltext":false,"cited_by_count":127,"citation_normalized_percentile":{"value":0.97201292,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"93","issue":"6","first_page":"1551","last_page":"1560"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9789999723434448},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.925000011920929},{"id":"https://openalex.org/keywords/extracellular-signal-regulated-kinase","display_name":"extracellular signal-regulated kinase","score":0.9300000071525574},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.781000018119812},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.7419999837875366},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.9549999833106995},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.9959999918937683},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.953000009059906},{"id":"https://openalex.org/keywords/subcellular-compartmentalization","display_name":"subcellular compartmentalization","score":0.9580000042915344},{"id":"https://openalex.org/keywords/depression-treatment","display_name":"depression treatment","score":0.41600000858306885},{"id":"https://openalex.org/keywords/chronic-drug-administration","display_name":"chronic drug administration","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.7213442325592041},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.5676339864730835},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.5430575609207153},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.47840699553489685},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.4703286588191986},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.46806278824806213},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4584602117538452},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4252278208732605},{"id":"https://openalex.org/C148762608","wikidata":"https://www.wikidata.org/wiki/Q3748185","display_name":"Hippocampal formation","level":2,"score":0.4233870208263397},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4182450473308563},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4009917080402374},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3961685597896576},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.20031148195266724},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16431638598442078},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15741455554962158}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002467","descriptor_name":"Cell Nucleus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002467","descriptor_name":"Cell Nucleus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003593","descriptor_name":"Cytoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003593","descriptor_name":"Cytoplasm","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005625","descriptor_name":"Frontal Lobe","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005625","descriptor_name":"Frontal Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1471-4159.2005.03149.x","doi":"https://doi.org/10.1111/j.1471-4159.2005.03149.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2005.03149.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:15935071","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15935071","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1489716577","https://openalex.org/W1783361713","https://openalex.org/W1825797577","https://openalex.org/W1899552864","https://openalex.org/W1950744654","https://openalex.org/W1952953777","https://openalex.org/W1969294711","https://openalex.org/W1969889001","https://openalex.org/W1984339303","https://openalex.org/W1990065094","https://openalex.org/W2008162127","https://openalex.org/W2013770758","https://openalex.org/W2023412671","https://openalex.org/W2046342486","https://openalex.org/W2052655524","https://openalex.org/W2060341782","https://openalex.org/W2075620663","https://openalex.org/W2078131594","https://openalex.org/W2079289532","https://openalex.org/W2081524299","https://openalex.org/W2110402980","https://openalex.org/W2118629625","https://openalex.org/W2118977349","https://openalex.org/W2121651624","https://openalex.org/W2126642279","https://openalex.org/W2128960139","https://openalex.org/W2130044807","https://openalex.org/W2146918064","https://openalex.org/W2154727263","https://openalex.org/W2168221314","https://openalex.org/W2168950597","https://openalex.org/W2171321056","https://openalex.org/W4249688612"],"related_works":["https://openalex.org/W2509828714","https://openalex.org/W1968800204","https://openalex.org/W6991297861","https://openalex.org/W2017727557","https://openalex.org/W2021892782","https://openalex.org/W2410542744","https://openalex.org/W1996443737","https://openalex.org/W2415286392","https://openalex.org/W1972252092","https://openalex.org/W1996567906"],"abstract_inverted_index":{"Accumulating":[0],"evidence":[1],"indicates":[2],"that":[3,47,62,86],"antidepressants":[4],"alter":[5],"intracellular":[6,182],"signalling":[7],"mechanisms":[8],"resulting":[9],"in":[10,20,67,109,116,130,135,169,199,224],"long-term":[11],"synaptic":[12],"alterations":[13],"which":[14],"probably":[15],"account":[16],"for":[17],"the":[18,29,52,57,80,83,136,140,144,155,170,196,200,219,225],"delay":[19],"clinical":[21],"action":[22,201],"of":[23,31,45,70,82,100,139,148,158,173,189,202,209,222,227],"these":[24],"drugs.":[25],"Therefore,":[26],"we":[27],"investigated":[28],"effects":[30,221],"chronic":[32],"fluoxetine":[33,64,203,223],"administration":[34],"on":[35,79,180,204],"extracellular":[36],"signal-regulated":[37],"kinase":[38],"(ERK)":[39],"1":[40,72,120,167],"and":[41,73,102,111,121,128],"2,":[42],"a":[43,92,177],"group":[44],"MAPKs":[46],"mediate":[48],"signal":[49],"transduction":[50],"from":[51],"cell":[53],"surface":[54],"downstream":[55],"to":[56,187],"nucleus.":[58],"Our":[59],"data":[60],"demonstrate":[61],"3-week":[63],"treatment":[65,84,101,226],"resulted":[66],"long-lasting":[68],"reduction":[69,208],"phospho-ERK":[71,119],"2.":[74],"Such":[75],"an":[76],"effect":[77,179],"depends":[78],"length":[81],"given":[85],"no":[87],"changes":[88],"were":[89,123],"observed":[90,108],"after":[91,97],"single":[93],"drug":[94],"injection":[95],"or":[96],"2":[98,122],"weeks":[99],"it":[103,163],"is":[104],"region":[105],"specific,":[106],"being":[107],"hippocampus":[110,131],"frontal":[112,141,174],"cortex":[113,175],"but":[114,132],"not":[115,153],"striatum.":[117],"Finally,":[118],"differently":[124],"modulated":[125],"within":[126],"nucleus":[127],"cytosol":[129],"similarly":[133],"reduced":[134],"same":[137],"compartments":[138],"cortex,":[142],"highlighting":[143],"specific":[145],"subcellular":[146],"compartmentalization":[147],"fluoxetine.":[149],"Conversely,":[150],"imipramine":[151],"did":[152],"reduce":[154],"hippocampal":[156],"phosphorylation":[157,168],"both":[159],"ERK":[160,166,210],"subtypes":[161],"whereas":[162],"selectively":[164],"increased":[165],"cytosolic":[171],"compartment":[172],"suggesting":[176],"drug-specific":[178],"this":[181,205],"target.":[183],"These":[184],"results":[185],"point":[186],"modulation":[188],"phosphorylation,":[190],"rather":[191],"than":[192],"altered":[193],"expression,":[194],"as":[195],"main":[197],"target":[198],"pathway.":[206],"The":[207],"1/2":[211],"function":[212],"herein":[213],"reported":[214],"may":[215],"be":[216],"associated":[217],"with":[218],"therapeutic":[220],"depression.":[228]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1524934458","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
